In a press release issued this week, the European Platform for the Responsible Using of Medicines in Animals (EPRUMA) says it welcomes the scientific advice of the European Medicines Agency (EMA) with recommendations for antimicrobials to be reserved for human use only.

Following a scientific assessment that takes into account reports from European Centre for Disease Prevention and Control (ECDC), the European Food Safety Authority (EFSA) and EMA as well as categorizations put forward by Antimicrobial Advice Ad Hoc Expert Group (AMEG), the World Health Organization (WHO) and the World Organization for Animal Health (OIE), as outlined in the advice, EPRUMA is calling on the European Commission to propose an implementing act following this scientific approach.

The organization says this is in line with the EU's One Health approach to addressing the challenge of antimicrobial resistance and the approach taken for establishing this recommendation has been based on the prevailing situation regarding which antibiotics are critical for human health in the EU. EPRUMA also recognizes the efforts made to ensure that every antimicrobial on the list has been assessed individually using the three criteria provided for in the Commission Delegated Act published in May 2021.

In the statement, EPRUMA said "Significant effort has been made by the EMA to assess why specific antimicrobials were or were not on the list reserved for human use only, referencing the best scientific knowledge and insight available at this time."

EPRUMA says it remains committed to promoting the responsible use of antibiotics and to fighting antimicrobial resistance through the One Health approach supported by the European Commission.

Source: European Platform for the Responsible Using of Medicines in Animals, which is solely responsible for the information provided, and wholly owns the information. Informa Business Media and all its subsidiaries are not responsible for any of the content contained in this information asset.